OCS
OCS
NASDAQ · Pharmaceuticals

Oculis Holding Ag

$11.52
-0.15 (-1.29%)
As of Jun 23, 2:00 PM ET ·
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Buy 15 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target +137.1% upside
Low Target $14.95
Average Target $27.31
High Target $37.18
Current Price $11.52
Current
$11.52
Target
$27.31
$14.95 $27.31 avg $37.18
Scenario Analysis
Bear Case
$14.95
29.8%
Low target
Base Case
$27.31
+137.1%
Avg target
Bull Case
$37.18
+222.7%
High target
Risk/Reward
7.5x
Highly favorable
Price in Context
52-Week High
$34.48
-66.6% from high
52-Week Low
$10.52
+9.5% from low
Target vs 52W High
$27.31
-20.8% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +20.2%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +25.3%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +33.2%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +37.1%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +214.2%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +173.1%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -34.5%